FELICIONI, LARA BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 1.353
AS - Asia 1.082
EU - Europa 971
SA - Sud America 121
AF - Africa 20
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.554
Nazione #
US - Stati Uniti d'America 1.324
SG - Singapore 434
CN - Cina 286
GB - Regno Unito 153
UA - Ucraina 137
IE - Irlanda 118
IT - Italia 112
SE - Svezia 106
RU - Federazione Russa 102
VN - Vietnam 102
BR - Brasile 99
FR - Francia 89
TR - Turchia 82
DE - Germania 70
IN - India 60
FI - Finlandia 32
HK - Hong Kong 24
TW - Taiwan 19
CA - Canada 18
PL - Polonia 16
BD - Bangladesh 11
JP - Giappone 10
MX - Messico 10
AR - Argentina 9
KR - Corea 9
IQ - Iraq 8
MY - Malesia 7
BE - Belgio 6
CZ - Repubblica Ceca 6
ES - Italia 6
ID - Indonesia 6
IR - Iran 5
PK - Pakistan 5
VE - Venezuela 4
ZA - Sudafrica 4
AU - Australia 3
EG - Egitto 3
LT - Lituania 3
SA - Arabia Saudita 3
UG - Uganda 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
ET - Etiopia 2
EU - Europa 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
NL - Olanda 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
GD - Grenada 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
LI - Liechtenstein 1
MN - Mongolia 1
MT - Malta 1
PY - Paraguay 1
SN - Senegal 1
TH - Thailandia 1
Totale 3.554
Città #
Singapore 342
Chandler 204
Jacksonville 153
San Jose 134
Dublin 117
Beijing 100
Ashburn 96
Southend 70
Princeton 58
Izmir 52
Nanjing 47
Dallas 45
Los Angeles 41
Altamura 30
Ann Arbor 26
Ho Chi Minh City 26
Santa Clara 26
Cambridge 25
The Dalles 25
Wilmington 23
Tongling 22
Boardman 21
Hanoi 20
Munich 19
Hong Kong 18
New York 15
Dearborn 14
Nanchang 14
Taichung 14
Warsaw 13
Buffalo 12
Moscow 12
Chennai 11
Denver 11
Orem 11
Redondo Beach 9
Tianjin 9
Atlanta 8
Kunming 8
London 8
Rome 8
Seoul 8
Augusta 7
Hebei 7
Woodbridge 7
Brooklyn 6
Brussels 6
Collecorvino 6
Council Bluffs 6
Da Nang 6
Houston 6
Montreal 6
São Paulo 6
Tokyo 6
Washington 6
Frankfurt am Main 5
Grevenbroich 5
Guangzhou 5
Jinan 5
Milan 5
Turku 5
Baghdad 4
Boston 4
Brno 4
Campinas 4
Haiphong 4
Hangzhou 4
Helsinki 4
Jiaxing 4
Kuala Lumpur 4
Mexico City 4
Mumbai 4
New Delhi 4
Ninh Bình 4
Pescara 4
Poplar 4
Shenyang 4
Stockholm 4
Toronto 4
Verona 4
Belo Horizonte 3
Bengaluru 3
Biên Hòa 3
Buenos Aires 3
Bến Tre 3
Cassina de' Pecchi 3
Cleveland 3
Dong Ket 3
Falls Church 3
Gloucester 3
Istanbul 3
Kampala 3
Ottawa 3
Rio de Janeiro 3
San Mateo 3
Sydney 3
Uberlândia 3
Zhengzhou 3
Addis Ababa 2
Amman 2
Totale 2.170
Nome #
Assessing EGFR mutations. 242
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays 182
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 177
AKT1(E17K) in human solid tumours 144
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. 136
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma. 134
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. 133
Mutational profile of GNAQQ209 in human tumors. 129
Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer 129
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. 128
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. 127
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice 125
Quantification of EGFR Mutations in Plasma of NSCLC Patients: An Early Predictor of Clinical Response to Tyrosine Kinase Inhibitor 124
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation 123
Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications. 121
Correspondence - In Reply - Limitations of Single-Strand Conformation Polymorphism Analysis As a High-Throughput Method for the Detection of EGFR Mutations in the Clinical Setting 118
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. 118
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. 118
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. 115
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. 114
Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. 114
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. 113
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. 112
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. 112
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones. 107
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. 103
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer. 99
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: A study of the Italian NGS Network 66
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor 62
Totale 3.625
Categoria #
all - tutte 13.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 23 0 11
2021/2022163 5 2 1 28 8 12 4 18 15 14 16 40
2022/2023511 37 81 29 67 55 94 20 31 73 3 11 10
2023/2024212 19 4 17 7 17 47 45 6 1 16 2 31
2024/2025630 32 107 100 25 16 34 15 22 54 35 84 106
2025/20261.148 85 77 95 155 147 111 195 86 118 79 0 0
Totale 3.625